SUN PHARMACEUTICAL INDUSTRIES LIMITED vs MEGHMANI LIFESCIENCES LIMITED

Judgment text excerpt

J-ComsApeal-44382-2025-C.odt rajshree IN THE HIGH COURT OF JUDICATURE AT BOMBAY ORDINARY ORIGINAL CIVIL JURISDICTION COMMERCIAL APPEAL (L) NO.42382 OF 2025 WITH INTERIM APPLICATION (L) NO.42454 OF 2025 IN COMMERCIAL APPEAL (L) NO.42382 OF 2025 WITH COMMERCIAL APPEAL(L) NO.42382 OF 2025 IN INTERIM APPLICATION (L) NO.9484 OF 2025 WITH COURT RECEIVER REPORT NO.220 OF 2025 IN COMMERCIAL IP SUIT (L) NO.9352 OF 2025 Sun Pharmaceutical Industries Ltd. .. Appellant vs. Meghmani Lifesciences Ltd. & Anr. .. Respondents Mr.Hiren Kamod a/w Mr.Prem Khullar, Mr.Rahul Dhote, Mr.Shwetank Tripathi, Ms.Radhika Mehta and Vidit Desai i/b ANM Global, for the Appellant. Mr.Rashmin Khandekar a/w Mr.Anand Mohan, Mr. Ashutosh Kane, Ms.Vedangi Soman and Ms.Avani Panchabhai i/b W.S. Kane & Co. for Respondent No.2. Mr.Nitin Pawar, Court Receiver, present. CORAM : BHARATI DANGRE & MANJUSHA DESHPANDE, JJ DATE : 8th APRIL 2026 Digitally signed RAJSHREE by RAJSHREE KISHOR MORE KISHOR MORE Date: 2026.05.15 12:12:56 +0530 1/41 J-ComsApeal-44382-2025-C.odt JUDGMENT (PER BHARATI DANGRE, J) : 1 Sun Pharmaceutical Industries Limited, Appellant/Plaintiff , a Public Limited Company incorporated under the Companies Act, 1956, is engaged in the business of manufacturing, trading, marketing, selling and/or distributing medicinal and pharmaceutical preparations. It claims to be number one pharma company in India with 8.3% market share and ranked no.1 by prescription with 12 different classes of doctors. The Plaintiff’s products claim to have the hallmark of technology-based differentiation covering full range of dosage forms including tablets, capsules, injectables, inhalers, ointments, creams and liquids as it offer comprehensive product portfolio across various therapeutic segments. According to Sun Pharmaceuti